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The treatment of peripheral nerve injuries remains one of the greatest challenges of neurosurgery, as functional recover is rarely
satisfactory in these patients. Recently, biodegradable nerve guides have shown great potential for enhancing nerve regeneration. A
major advantage of these nerve guides is that no foreignmaterial remains after the device has fulfilled its task, which spares a second
surgical intervention. Recently, we studied peripheral nerve regeneration using chitosan-𝛾-glycidoxypropyltrimethoxysilane
(chitosan-GPTMS) porous hybrid membranes. In our studies, these porous membranes significantly improved nerve fiber
regeneration and functional recovery in rat models of axonotmetic and neurotmetic sciatic nerve injuries. In particular, the number
of regenerated myelinated nerve fibers and myelin thickness were significantly higher in rat treated with chitosan porous hybrid
membranes, whether or not they were used in combination with mesenchymal stem cells isolated from the Wharton’s jelly of the
umbilical cord. In this review, we describe our findings on the use of chitosan-GPTMS hybrids for nerve regeneration.
1. Introduction
Nerve regeneration is a complex biological process. While
approaches for peripheral nerve repair have improved over
the last few decades, functional recovery is usually incom-
plete. As a result, much attention has been given by
researchers and clinicians to cell-based therapies and tissue
engineering [1–4]. Autografts are commonly used to treat
peripheral nerve damage caused by accidents or diseases;
however, there are several disadvantages to this approach
[5, 6]. In addition, although microsurgical techniques have
substantially improved, peripheral nerve repair remains one
of the greatest challenges of neurosurgery [2, 4, 7, 8]. Many
basic research and clinical studies have demonstrated that
entubulation promotes peripheral nerve reconstruction in
neurotmetic injuries with a gap, permitting reconstruction
of the defect without tension at the suture and creating a
favorable microenvironment at the injury site.The implanted
tube guides hasten Wallerian degeneration and promote
regeneration from the lesioned proximal end without the
disadvantages of a graft procedure. Over the last decade,
many researchers have used artificial biomaterials to produce
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these tube guides [9–11]. Nerve cells can regenerate into
the cylinder-shaped tubes, where the microenvironment
promotes regeneration towards the distal nerve stump.These
tube guides can be made of different biomaterials, and they
allow the incorporation of various molecules and cellular
systems [12]. The tube guides should be biocompatible,
nontoxic, biodegradable, permeable, and noninflammatory,
like other tissue engineering scaffolds. They should prevent
fibrous scar tissue invasion but allow local revascularization
to improve nutrient and oxygen supply. Consequently, appro-
priate biomaterial microporosity is fundamental to a positive
clinical outcome [13–26]. The tube guides should also have
an adequatemechanical strength tomaintain a stable support
structure for nerve regeneration over the healing period [27].
2. Nerve Conduits Prepared from
Chitosan-Based Materials
Chitosan and its complexes have been studied for a num-
ber of biomedical applications, including wound dressings,
drug delivery systems, and space-filling implants, because
of their biocompatibility, biodegradability, wound-healing,
and antibacterial properties [28]. Nerve conduits derived
from chitosan have favorable mechanical properties and slow
biodegradability. Many chitosan nerve conduits modified
with other biodegradable polymers have been investigated
by numerous laboratories. Optimal hydrophilicity has been
found to be essential for preventing fibrous scar tissue
invasion and for promoting nerve regeneration. Cheng et
al. prepared chitosan-poly(L-lysine) composites and reported
that their hydrophilic surfaces improved nerve cell affinity,
showing better results compared with collagen [29]. Gelatin
has also been blended with chitosan to improve elasticity
and enhance nerve cell affinity [30]. Cell differentiation on
chitosan films is also improved by blending with gelatin.
Wang et al. succeeded in obtaining regeneration across a large
nerve gap of 30mm using chitosan-polyglycolic acid (PGA)
[31]. The chitosan/PGA graft-reconstructed peripheral nerve
allowed the restoration of nerve continuity and functional
recovery, that is, locomotion, of the operated limb [31].
Chitosan nerve tube guides have also been modified
by some research groups with inorganic components. For
example, Ga¨rtner et al. prepared chitosan hollow tubes
from crab tendons [32] and modified them with apatite to
enhance mechanical strength, thereby preventing swelling.
After implantation in a neurotmetic model of sciatic nerve
injury with a 10 mm gap, the regenerated nerve tissues
contained newly formed vessels, and macrophages were
found to phagocytize the debris of the walls 4 weeks after
surgery, demonstrating appropriate Wallerian degeneration,
a crucial step toward regeneration.
Wallerian degeneration is the process of degeneration of
the axon distal to the site of transection. Once a peripheral
nerve has been transected, Wallerian degeneration of the
distal axons begins andmacrophages enter the area to remove
the myelin and axonal debris. The surrounding basement
membrane and Schwann cells play important roles in this
process. Schwann cells line up along the basementmembrane
tube and synthesize growth factors that attract axonal sprouts
formed at the terminal of the proximal segment of the severed
axon [8]. Adding a cellular system capable of producing
these important growth factors to a tube guide to direct
nerve regrowth will also improve the first and essential
stage of the regenerative process: Wallerian degeneration
[32]. The basement membrane tubes and the artificial tube
guides implanted using microsurgical techniques provide
pathways for the regenerating axons to correctly innervate
target muscles.The Schwann cells then remyelinate the newly
formed axons; however, the newly formed myelin is thinner
than normal and the newly formed internodes are shorter
than normal [32].
Yamaguchi et al. [33, 34] modified chitosan/apatite com-
posite tubes with laminin peptides to improve nerve regen-
eration [34]. The tubes incorporating laminin-1 and laminin
peptides induced a more rapid regenerative response by
improving the migration of Schwann cells and the bridging
of axons. However, the recovery of nociceptive function was
delayed compared with autograft treatment [34]. Chitosan-
gold nanocomposite materials have also been studied and
tested for use as nerve conduits [35]. The gold nanoparticles
improved the mechanical strength of the chitosan. The
gold in the composite affected the behavior of neural stem
cells (NSCs) in vitro. Because NSCs are multipotent stem
cells that can follow multiple differentiation pathways, using
this differentiated cellular system may allow resident cell
replacement and create an environment that supports and
improves axon regeneration. The authors found that 50 ppm
of gold nanoparticles stimulated cell proliferation and gene
expression. After 6 weeks of implantation, a better and faster
functional recovery was observed in animals treated with
the chitosan-gold nanocomposite and NSCs compared with
the composite alone in their model of neurotmetic injury
with a gap. Histomorphometric analysis revealed that the
number of myelinated axons in the regenerated nerve fibers
was higher in animals where the nerve was reconstructed
with the chitosan-gold nanocomposite and NSCs [35].
3. Challenges for Nerve Repair Using
Chitosan-Siloxane Hybrids
Our grouphas synthesized inorganic-organic hybrids derived
from chitosan and 𝛾-glycidoxypropyltrimethoxysilane
(GPTMS) units using sol-gel methods [36–42]. Different
formats can be easily obtained, such as solid membranes,
porous membranes, hydrogels, and tube guides. 29Si and
13C CP-MAS NMR analysis, FT-IR spectroscopy, ninhydrin
assay, and contact angle analysis revealed the following
physical characteristics of these hybrids [36, 38]: (1) the
amino groups in chitosan reacted with the epoxy groups
and interacted with silanol groups derived from GPTMS,
(2) the silanol groups condensed to form 2D or 3D siloxane
networks, and (3) some of the silanol groups remained in
the hybrids and were orientated towards the surface of the
structure.
The solid chitosan hybrid membranes allowed for good
proliferation and differentiation of the human osteoblastic
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Table 1: Histomorphometrical assessment of the regenerated rat sciatic nerve wrapped with the solid or porous membranes during a healing
period of 12 weeks after axonotmetic injury.
Group Density(N/mm2)
Number
(N)
Fiber diameter
(mm)
Axon diameter
(mm)
Myelin thickness
(mm)
Control 10,123 ± 8,340 7,621 ± 198 8.27 ± 0.29 5.34 ± 0.23 1.21 ± 0.05
Crush 18,452 ± 1,952 10,180 ± 964 5.31 ± 0.34 4.12 ± 0.32 0.60 ± 0.08
Solid membrane 17,196 ± 3,364 9,774 ± 359 5.77 ± 0.45 4.54 ± 0.35 0.62 ± 0.06
Porous membrane 14,210 ± 1,600 7,780 ± 1,053 6.72 ± 0.26 5.00 ± 0.19 0.86 ± 0.05
NEUROLAC
(commercial PLGA nerve guided tube) [31] 21,982 ± 1,927 10,532 ± 2,195 3.49 ± 0.11 — 0.40 ± 0.02
cell line MG63 and harvested human bone marrow cells. The
attachment, proliferation, and alkaline phosphatase (ALP)
activity ofMG63 cells were higher when cultured on chitosan
hybrid membranes compared with chitosan membranes [36,
38]. Human bone marrow cells were found to produce
mineralized matrix on the hybrid chitosan membranes even
without supplementation of the culture medium with dex-
amethasone [38], which is commonly used to improve the
proliferation and differentiation of osteoblastic cells [43].
The porous hybrid chitosan membranes have interconnected
pores with a size between 50 and 150 𝜇m and a very high
porosity, normally more than 85% [37]. The cells adhere on
the pore walls with long and numerous pseudopodia and are
able to proliferate and establish connections with each other
even in the middle of the porous hybrid chitosan membranes
[37].
Amado et al. studied nerve regeneration using solid and
porous chitosan-GPTMSmembranes in a standardized crush
or axonotmetic injury of the rat sciatic nerve [44]. The 3
mm long axonotmetic lesion was wrapped with solid or
porous chitosan-GPTMS membranes. Functional recovery
was evaluated using the sciatic functional index, the static
sciatic index, the extensor postural thrust (EPT), the with-
drawal reflex latency (WRL), and ankle kinematics [45–
48]. Nerve fiber regeneration was also assessed morpholog-
ically using quantitative stereological analysis and electron
microscopy. The porous hybrid chitosan membrane signif-
icantly improved nerve fiber regeneration in their mode,
assessed using functional and morphological criteria, in
comparison with untreated animals or animals treated with
the solid membrane. The numbers of fibers and axons and
fiber size andmyelin thickness were significantly improved in
the chitosan porous membrane groups (Table 1). Functional
recovery also improved during the healing period of 12weeks,
as evaluated using the EPT and WRL tests. The porous
hybrid chitosan membranes, which have interconnected
pores, permit an adequate revascularization of the regener-
ating tissue and help restore metabolic communication with
the surrounding microenvironment, including nutrient and
O
2
exchange [37]. These physicochemical properties help
enhance nerve regeneration likely by promoting Schwann cell
proliferation, neurite extension, and myelination [49–51].
Simo˜es et al. tested the histocompatibility of the bio-
materials developed for nerve regeneration by implanting
the solid and porous membranes subcutaneously in the rat
model. These membranes were subsequently used in exper-
iments on sciatic nerve regeneration after axonotmetic and
neurotmetic injuries [49]. The porous membranes induced
a robust infiltration by multinucleated giant cells and some
mast cells, whereas the solid membranes elicited mild fibrous
capsule formation and a discrete inflammatory reaction.
Differences in the inflammatory reaction might underlie the
comparatively better regeneration obtained with the porous
membranes. It should be noted that the porous membranes
have a higher surface/volume ratio than the solid ones.
Greater contact with the host immune system might cause
the substantial cellular infiltration [49].
Simo˜es et al. investigated the effect of the porous
membranes in surgical neurotmetic repair either by direct
suture, autograft, or tubulization and also compared a tube
guide made of poly(lactide-co-glycolic) acid, where the two
monomers, the lactic acid and the glycolic acid, were in a ratio
of 90 : 10 (PLGA 90 : 10) [50]. As shown in Figure 1, the rats
were divided into the following six experimental groups of
six or seven animals each: Group 1, end-to-end neurorrhaphy
wrapped by the porous membrane (End-to-EndChitIII);
Group 2, 10mm nerve gap bridged by an autologous nerve
graft wrapped by the porous membrane (Graft180∘ChitIII);
Group 3, 10mm nerve gap bridged by the porous membrane-
like tube (GapChitIII); Group 4, 10mm nerve gap bridged
by an autologous nerve graft (Graft180∘); Group 5, 10mm
nerve gap bridged by PLGA 90 : 10 tube guides (PLGA);
and Group 6, end-to-end neurorrhaphy alone (End-to-End).
After 2 weeks, the WRL test had to be interrupted at the
selected cut-off time of 12 s in all experimental animals in the
different groups, except the ones in the End-to-End group.
The recovery of WRL was faster in the End-to-End and End-
to-EndChitIII groups during the healing period of 20 weeks.
After 2weeks, EPT commenced recovery and proceeded until
week 20 to a similar extent in all groups, except in the PLGA
group. In the groupswith the porous chitosan-GPTMhybrids
(End-to-EndChitIII, Graft180∘ChitIII, and GapChitIII), the
EPT recovery rate was faster than in the nonhybrids groups
(End-to-End, Graft180∘, and PLGA). Histomorphometric
analysis of the nerves was performed after the healing period
of 20 weeks, which showed that a good pattern of axon
regeneration occurred in all treated groups; however, the
pattern of regeneration in the PLGAgroupwas comparatively
inferior. In the GapChitIII group, nerve fibers regenerated
along the chitosan tube guide, which helped establish an
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Figure 1: Illustration of the surgical neurotmetic repair by direct suture, autograft, or tubulization.
extensive perineural connective architecture that contributed
to axonal fasciculation. The neuroregenerative properties of
the porous chitosan GPTMS might arise from its ability to
promote the expression of myelin genes.The silica ions in the
hybridmight induce expression of several glycoproteins, such
as RCL, cyclinD1, andCD44. [52, 53]. Our results suggest that
porous chitosan-GPTMS hybrids can be a valuable material
for fashioning nerve guides aimed at bridging nerve defects.
Schwann cells, mesenchymal stem cells, embryonic stem
cells, and marrow stromal cells have been extensively studied
for their ability to promote nerve regeneration. We focused
our research on the in vitro differentiated N1E-115 cell line
[47–51] and on mesenchymal stem cells (MSCs) from the
Wharton’s jelly of the umbilical cord [32]. In vivo experiments
using the rat sciatic nerve model were performed using the
porous hybrid chitosan membranes seeded with neuroglial-
like cells obtained from in vitro differentiated N1E-115 cells.
The combination of the porous hybrid membranes with
these neuroglial-like cells was tested in axonotmetic and
neurotmetic injuries.The implantation of cultured cells (N1E-
115 cells, MSCs, Schwann cells, and other cellular systems)
into defective nerves can be achieved using two different
techniques. The cellular system can be directly injected into
the neural scaffold that has been interposed between the
proximal and distal nerve stumps or around the crush injury
(in neurotmetic and axonotmetic injuries, resp.). Alterna-
tively, implantation can be achieved by preadding the cells
to the neural scaffold via injection or coculture (in most of
the cellular systems, it is allowed to form a monolayer), and
then the biomaterial with the cellular system is implanted into
the injured nerve [47–51]. The N1E-115 cell line is a mouse
neuroblastoma cell line that can undergo neuronal differenti-
ation in response to dimethylsulfoxide, adenosine 3󸀠;5󸀠-cyclic
monophosphate, or serum withdrawal [51, 54]. The cellular
system was tested in axonotmetic and neurotmetic lesions to
locally produce and deliver neurotrophic factors, which are
crucial for nerve regeneration. Also, this cellular system was
used as an inexpensive and easy in vitro cultured model of
stem cells [51, 54].
Simo˜es et al., in 2010, used the rat sciatic nerve model for
investigating the effect of porous hybrid chitosanmembranes
in a neurotmetic injury, used together with standard micro-
surgical repair methods (i.e., direct epineural end-to-end
suture without tension, inverted autograft, and tubulization)
[50]. Morphological analysis showed that nerve regeneration
had occurred when the porous hybrid chitosan membrane
was used in neurotmetic injuries. At week 20, it could be
observed that Wallerian degeneration was complete and
followed by the regrowth of axons and Schwann cell myelin-
ization. The results obtained with these membranes were
significantly better, in terms of functional andmorphological
recovery, compared with PLGA 90 : 10, where regeneration
was weak [50]. The favorable physicochemical properties of
porous hybrid chitosan membranes compared with regular
chitosan and the presence of silicamight underlie their ability
to enhance nerve regeneration [50]. The porous hybrid chi-
tosan membranes might provide better mechanical support
during nerve regeneration and, simultaneously, might work
as an inducer of nerve regeneration, supporting the survival
and ability of the Schwann cells to myelinate [50].
Light and electron microscopy analysis of PLGA 90 : 10
and chitosan tube guides containing in vitro differentiated
N1E-115 cells suggested that the impairment in nerve fiber
regeneration in these systems might have been caused by
the presence of a large number of neuroblastoma-like cells
colonizing large areas of the nerve profile, which might
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Table 2: Histomorphometrical assessment of the regenerated rat sciatic nerve, treated with hMSCs and porous membranes, during a healing
period of 12 weeks after axonotmetic injury.
Group Density (N/mm2) Number (N) Fiber diameter (mm) Axon diameter (mm) Myelin thickness (mm)
CrushCell 20,200 ± 4,971 9,806 ± 2,695 5.31 ± 0.19 3.74 ± 0.49 0.78 ± 0.10
CrushChCell 21,514 ± 6,308 11,413 ± 3,752 4.90 ± 0.97 3.41 ± 0.72 0.75 ± 0.14
CrushCh 15,533 ± 7,713 7,982 ± 3,092 5.29 ± 1.05 3.50 ± 0.55 1.02 ± 0.22
Control 15,905 ± 287 7,666 ± 190 6.66 ± 0.12 4.26 ± 0.07 1.19 ± 0.03
have interfered with nerve regeneration inside the nerve
guides. Interestingly, the presence of many blood vessels was
observed inside the large neuroblastoma-like clusters, sug-
gesting that transplanted cells can deprive the regenerating
nerve fibers of blood supply [46, 50]. It should be noted
that neurotrophic factors play an important role in nerve
regeneration after injury or disease, and it is conceivable
that if neurotrophic factors are applied in the close vicinity
of the injured nerve, their healing potency is optimized.
However, contrary to our initial hypothesis, the N1E-115
cells, in vitro differentiated into neuroglial-like cells, did not
facilitate either nerve regeneration or functional recovery
in neurotmetic injuries when used in combination with
PLGA 90 : 10 or porous chitosan membranes. Indeed the
presence of this cellular system reduced the number and
size of the regenerated fibers, thus suggesting that this type
of cellular system can partially impair nerve regeneration,
at least from a morphological point of view. The impaired
axonal regeneration seems to be the result of N1E-115 cells
surrounding and invading the regenerating nerve, sincemany
of these cells were seen colonizing the nerve and might have
deprived the regenerating nerve fibers of blood supply. Taken
together, these results suggested that the N1E-115 cells do not
promote nerve healing, and their usemight even impair nerve
regeneration. For this reason, we started using human MSCs
[46, 50].
Ga¨rtner et al. seeded the porous membranes with undif-
ferentiated human MSCs (hMSCs) isolated from Wharton’s
jelly [32]. MSCs isolated from Wharton’s jelly are capable
of being differentiated into multiple mesodermal cell types,
including skeletal muscle and neurons [55–57], and therefore
may be valuable for repairing the peripheral nervous system.
In the study, the axonotmetic lesion of 3mm in the rat
sciatic nerve was wrapped with (1) the porous membrane
or (2) the porous membrane covered with a monolayer of
undifferentiated hMSCs or (3) was directly infiltrated with a
suspension of hMSCs. WRL data showed a slightly delayed
recovery in the porous membrane group compared with
the other groups during the healing period of 12 weeks. In
contrast, EPT performance was similar in all treated groups
during the healing period. Fiber regeneration was good
in all treated experimental groups. The regenerated nerves
contained smaller myelinated fibers than normal nerves
without injury, which is expected with axon regeneration
(Table 2). The myelin thickness in the regenerated nerves
was higher in groups wrapped with the porous membranes
alone, confirming previous results [44, 49, 52, 53], or when
the lesion site was directly infiltrated with undifferentiated
hMSCs [32]. The negative effects observed with the neo-
plastic neuroblastoma-derived N1E-115 cell line [44] were
not observed with hMSCs. hMSCs enhanced functional
recovery by modulating the inflammatory reaction during
Wallerian degeneration and by stimulating the production of
growth factors. hMSCs may have an even more pronounced
effect when applied to human injures. Taken together, these
findings demonstrate the therapeutic potential of hMSC and
porous hybrid chitosan membranes in promoting myelin
production in surgically reconstructed nerves after axonot-
metic and neurotmetic injuries. These stem cells and hybrid
porous chitosanmembranesmay also have clinical efficacy in
neurodegenerative diseases that are typified by demyelination
[58].
4. Conclusions
In vivo studies indicate that chitosan-GPTMS porous hybrid
membranes are a very promising clinical tool in periph-
eral nerve reconstructive surgery. The combination of the
chitosan-GPTMS porous hybrid membranes and hMSCs
has a slight advantage in comparison to untreated controls.
An enhancement of nerve regeneration was observed when
hMSCs or the porous hybrid chitosan membranes were
used alone but not when used in combination. An increase
in myelin production, visible as higher myelin thickness
measured by histomorphometry, was observed in surgically
reconstructed nerves after axonotmetic and neurotmetic
injury. These findings demonstrate the therapeutic potential
of these cells and biomembranes in neurodegenerative dis-
eases that are typified by demyelination. Further investigation
using animal models is required to determine the efficacy of
these systems in the treatment of critical nerve defects and
neurodegenerative diseases.
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